Cancer genomics and single-cell technologies

This webinar is being rescheduled due to technical difficulties on the original broadcast date. Please check back for updates. Thank you for your understanding.

Recent advances in next-generation sequencing technologies have enabled cancer research at an unprecedented resolution. These approaches are revealing new insights into cancer genomes and the diverse tumor ecosystem, and their impact on cancer pathogenesis, progression, and therapy. Additionally, the development of sophisticated computational tools is critical for the analysis and biological interpretation of complex sequencing datasets.

In this webcast, three experts discuss cancer genomics and single-cell technologies, the unique analytical considerations and potential to yield biological discoveries. Dana Pe’er will introduce single-cell technologies and tools, followed by a presentation by Rameen Beroukhim on genomic profiling and cancer evolution. Finally, Serena Nik-Zainal will cover mutational signature analysis. These presentations will be followed by a live discussion of advances, challenges, and future outlook on how these approaches are shaping cancer research.

Dana Pe’er
Chair of the Program in Computational and Systems Biology and Scientific Director of the Gerry Center for Metastasis and Tumor Ecosystems
Memorial Sloan Kettering Cancer Center

Rameen Beroukhim
Associate Professor of Medicine at Harvard Medical School, a Physician at the Dana-Farber Cancer Institute
Associate Physician at Brigham and Women’s Hospital, and an Associate Member of the Broad Institute

Serena Nik-Zainal
CRUK Advanced Clinician Scientist
University of Cambridge